| For: | Karidis NP, Kouraklis G, Theocharis SE. Platelet-activating factor in liver injury: A relational scope. World J Gastroenterol 2006; 12(23): 3695-3706 [PMID: 16773686 DOI: 10.3748/wjg.v12.i23.3695] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3695.htm |
| Number | Citing Articles |
| 1 |
Yosuke Osawa, Hironari Kawai, Keigo Nakashima, Yuichi Nakaseko, Daisuke Suto, Keisuke Yanagida, Tomomi Hashidate-Yoshida, Taizo Mori, Sachiyo Yoshio, Takaaki Ohtake, Hideo Shindou, Tatsuya Kanto, Herve Le Stunff. Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0303296
|
| 2 |
Haralabos C. Karantonis, Georgios Gribilas, Ioannis Stamoulis, Constantinos Giaginis, Chara Spiliopoulou, Gregorios Kouraklis, Constantinos Demopoulos, Stamatios E. Theocharis. Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis. Digestive Diseases and Sciences 2010; 55(2) doi: 10.1007/s10620-009-0745-0
|
| 3 |
Hiromi Funayama, Ling Huang, Tadasu Sato, Yuko Ohtaki, Yoshinobu Asada, Takashi Yokochi, Haruhiko Takada, Shunji Sugawara, Yasuo Endo. Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide. International Immunopharmacology 2009; 9(13-14) doi: 10.1016/j.intimp.2009.09.006
|
| 4 |
Chi Li, Yang-Jie Ru, Quan-Yue Lin, Guang-Chun Gao, Yu-Die Yang, Xiao-Qin Zhang, Jin-Lai Gao, Shi-Hui Liu, Chu-Wei Zheng, Lin Wang, Ya-Xin Zheng, Ji-Ming Wu. Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study. Fitoterapia 2022; 162 doi: 10.1016/j.fitote.2022.105290
|
| 5 |
Paraskevi Detopoulou, Tzortzis Nomikos, Elizabeth Fragopoulou, Smaragdi Antonopoulou. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers. Current Vascular Pharmacology 2021; 19(6) doi: 10.2174/1570161119666210628125239
|
| 6 |
Limin Feng, Ying Zhao, Guofang Feng, Yu Chen. Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-105
|
| 7 |
Eleonora Stanca, Gaetano Serviddio, Francesco Bellanti, Gianluigi Vendemiale, Luisa Siculella, Anna Maria Giudetti. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: Potential antiinflammatory effect of silybin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(12) doi: 10.1016/j.bbadis.2013.07.005
|
| 8 |
Alessandro Federico, Marcello Dallio, Carmelina Loguercio. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules 2017; 22(2) doi: 10.3390/molecules22020191
|
| 9 |
Pamela Czajka, Adam Przybyłkowski, Anna Nowak, Marek Postula, Marta Wolska, Dagmara Mirowska-Guzel, Anna Czlonkowska, Ceren Eyileten. Antiplatelet drugs and liver fibrosis. Platelets 2022; 33(2) doi: 10.1080/09537104.2021.1883574
|
| 10 |
Debra L. Laskin, Vasanthi R. Sunil, Carol R. Gardner, Jeffrey D. Laskin. Macrophages and Tissue Injury: Agents of Defense or Destruction?. Annual Review of Pharmacology and Toxicology 2011; 51(1) doi: 10.1146/annurev.pharmtox.010909.105812
|
| 11 |
D.L. Laskin, C.R. Gardner, J.D. Laskin. Comprehensive Toxicology. 2010; doi: 10.1016/B978-0-08-046884-6.00607-2
|
| 12 |
Gang Liu, Alan W. Baird, Marie J. Parsons, Kening Fan, David A. Skerrett‐Byrne, Prema M. Nair, Samwel Makanyengo, Jinbiao Chen, Rachel Neal, Bridie J. Goggins, Hock Tay, Andrea Mathe, Wai S. Soh, Kyra Minahan, Phil M. Hansbro, Brett Nixon, Geoffrey W. McCaughan, Gerald Holtmann, Sean P. Colgan, Simon Keely. Platelet activating factor receptor acts to limit colitis‐induced liver inflammation. The FASEB Journal 2020; 34(6) doi: 10.1096/fj.201901779R
|
| 13 |
Erika Ramos-Tovar, Pablo Muriel. Dietary Interventions in Liver Disease. 2019; doi: 10.1016/B978-0-12-814466-4.00009-4
|
| 14 |
Enrique Ángel-Gomis, Esther Caparrós, Isabel Gómez-Hurtado, Sebastián Martínez-López, Ani Gasparyan, Anabel Fernández-Iglesias, Benedikt Simbrunner, Paula Boix, Jordi Gracia-Sancho, Oriol Juanola, Rubén Francés. Antagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis. Biomedicine & Pharmacotherapy 2025; 193 doi: 10.1016/j.biopha.2025.118804
|
| 15 |
Alexandros Tsoupras, Ronan Lordan, Ioannis Zabetakis. Inflammation, not Cholesterol, Is a Cause of Chronic Disease. Nutrients 2018; 10(5) doi: 10.3390/nu10050604
|